Astellas Pharma Inc. (TYO:4503)
Japan · Delayed Price · Currency is JPY 2,245.00
-65.50 (-2.83%)
Oct 2, 2026, 3:30 PM JST
Astellas Pharma Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Astellas Pharma stock has a consensus rating of "Buy" and an average price target of ¥2,529. The average 1-year stock price forecast is 12.66% higher than the current stock price, while the lowest is ¥2,000 (-10.91%) and the highest is ¥3,100 (+38.08%).
Price Target: ¥2,529 (+12.66%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Astellas Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 9 | 8 | 8 | 8 | 8 | 8 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 13 | 13 | 13 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Daiwa No rating | Daiwa | Sell Maintains ¥1,700 → ¥2,000 | Sell | Maintains | ¥1,700 → ¥2,000 | -10.91% | Sep 30, 2026 |
Unknown Analyst Mizuho Securities No rating | Mizuho Securities | Hold Maintains ¥2,440 | Hold | Maintains | ¥2,440 | +8.69% | Sep 14, 2026 |
Unknown Analyst CLSA No rating | CLSA | Buy Maintains ¥3,000 | Buy | Maintains | ¥3,000 | +33.63% | Aug 18, 2026 |
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Hold Maintains ¥2,300 → ¥2,500 | Hold | Maintains | ¥2,300 → ¥2,500 | +11.36% | Aug 17, 2026 |
| Citi | Citi | Hold Maintains ¥2,470 | Hold | Maintains | ¥2,470 | +10.02% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
2.35T
from 2.14T
Increased by 9.69%
Revenue Next Year
2.19T
from 2.35T
Decreased by -6.70%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is JPY.